Modulatory role of estradiol in nicotinic antinociception in adult female rats.
OBJECTIVE
Differences in the response to nicotinic analgesia in males and females have been suggested by recent studies, and such differences are presumed to be due to the regulatory effects of gonadal hormones. The aim of this study was to investigate nicotinic antinociception and the effect of estradiol (E2) on this response in female rats.


METHODS
Ovariectomized female rats were implanted with subcutaneous silastic tubes containing E2. On day 28 after implantation, epibatidine, a high-potency nicotinic acetylcholine receptor (nAChR) agonist, was administered intrathecally, and antinociception at the spinal level was assessed by the tail-flick test. In addition, immunohistochemical staining for nAChRalpha4 was performed in spinal cord sections.


RESULTS
We found that female rats showed shorter nociceptive latencies than males, but there was no effect of ovarian status. However, OVX significantly increased epibatidine-induced antinociception compared to that in intact females, and this increase was attenuated by E2 treatment. In addition, OVX resulted in increased nAChRalpha4 immunostaining in the dorsal horn compared to that in intact females, and this increase was also attenuated by E2 treatment.


CONCLUSIONS
Results of this study provide new evidence that E2 modulates epibatidine-induced antinociception at the spinal level in female rats.
Chen
Yu
Y
Department of Anesthesiology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, PR China.
Cui
Yu
Y
Lin
Jian-Wen
JW
Xiang
Qiu-Ling
QL
Liu
Wei-Feng
WF
Wang
Ting-Huai
TH
D000700:Analgesics; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000494:pharmacology; D004958:Estradiol / Q000097:blood / Q000494:pharmacology*; D005260:Female; D007150:Immunohistochemistry; D007278:Injections, Spinal; D008297:Male; D009538:Nicotine / Q000494:pharmacology*; D018722:Nicotinic Agonists / Q000494:pharmacology*; D018733:Nicotinic Antagonists / Q000494:pharmacology; D010052:Ovariectomy; D010147:Pain Measurement / Q000187:drug effects; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D011930:Reaction Time / Q000187:drug effects; D011978:Receptors, Nicotinic / Q000187:drug effects; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism
D000700:Analgesics; D019086:Bridged Bicyclo Compounds, Heterocyclic; D018722:Nicotinic Agonists; D018733:Nicotinic Antagonists; D011725:Pyridines; D011978:Receptors, Nicotinic; D004958:Estradiol; D009538:Nicotine; C082748:epibatidine